Product Knowledge

BIT 20% vs MIT and CMIT Preservatives: How to Choose

BIT, MIT, and CMIT are the three most widely used isothiazolinone preservatives in industrial and consumer formulations. They share a chemical family and mode of action but differ in potency, regulatory status, and sensitisation profile. This guide compares them on the factors that actually affect a formulation decision.

Published 2026-01-15Updated 2026-07-27By Vasudev Chemo Pharma Technical TeamReviewed by Vasudev Chemo Pharma Formulation & Regulatory Affairs Team, Industrial Chemistry, Biocide Formulation

What Is the Difference Between BIT, MIT, and CMIT?

BIT (CAS 2634-33-5), MIT (CAS 2682-20-4), and CMIT (CAS 26172-55-4) are isothiazolinone biocides that disrupt microbial cell metabolism. BIT is used at higher concentrations (hundreds of ppm) because it is less potent per unit weight; MIT and CMIT are used at single- to low-double-digit ppm and are typically supplied as a CMIT/MIT blend.

All three belong to the isothiazolinone class and share a broadly similar mode of action, but differ in molecular structure, potency, and typical use concentration. BIT requires a higher dose to achieve equivalent kill because it is comparatively less potent per unit weight than MIT or CMIT, but published toxicological assessments generally report a lower sensitisation rate for BIT than for CMIT specifically. CMIT is typically supplied and used in combination with MIT — the well-known CMIT/MIT blend — at low ppm levels, delivering fast-acting, broad-spectrum protection, but has drawn particular regulatory and dermatological scrutiny over sensitisation concerns in recent years.
BIT, MIT, and CMIT — key comparison data
PropertyBITMITCMIT
CAS number2634-33-52682-20-426172-55-4
Typical use concentrationHundreds of ppm (0.02%-0.1% active)Single to low double-digit ppmSingle to low double-digit ppm, usually blended with MIT
EU BPR active-substance status (PT6/PT13)Approved — Implementing Regulation (EU) 2025/929, May 2025Under review programme, PT6 approval pending per Implementing Regulation (EU) 2025/1257Evaluated jointly with MIT as CMIT/MIT mixture
EU leave-on cosmetic useNot separately listed with an Annex V leave-on entry; check current CosIng statusNot permitted in leave-on cosmetics since 2017 (Regulation (EU) 2017/1224)Not permitted in leave-on cosmetics; rinse-off capped at 0.0015% of the 3:1 mixture

How Do BIT, MIT, and CMIT Compare on Efficacy Spectrum?

BIT is effective against a broad spectrum of gram-positive and gram-negative bacteria, fungi, and yeasts, and is notably stable at high pH and elevated temperature. MIT and CMIT are more potent per ppm but have tighter formulation error margins and are more sensitive to certain matrices.

BIT's documented stability at alkaline pH and elevated temperature is particularly valuable for high-pH latex paint systems and processes involving a heating step. MIT and CMIT are dosed at much lower ppm levels than BIT, reflecting higher intrinsic potency, but this also narrows the margin for formulation error. In practice, many commercial preservative systems combine BIT with a fast-acting isothiazolinone (or an entirely different biocide class) to achieve broad-spectrum, fast-knockdown protection: BIT provides sustained, stable, longer-term protection, while the companion biocide provides rapid initial kill.

Which Isothiazolinone Should I Choose for My Formulation?

Choose BIT alone for high-pH or high-temperature industrial applications, or where cosmetic regulatory limits restrict MIT/CMIT use. Consider a BIT plus MIT/CMIT blend when a single biocide fails preservative efficacy testing or the application benefits from a dual mode of action.

Choose BIT alone when the application requires high pH or temperature stability (alkaline detergents, hot-fill processes), the formulation is subject to cosmetic regulatory limits restricting MIT/CMIT, or a lower sensitisation profile relative to CMIT is a priority for the target market. Consider a blend when the formulation faces an unusually severe or fast-developing microbial challenge, a single-biocide dose fails preservative efficacy testing, or the application benefits from a dual mode-of-action approach to reduce the risk of resistant organisms developing over time. Whichever approach is chosen, validate the final formulation with a preservative efficacy (challenge) test under ASTM D2574, ASTM E640, or ISO 11930 as applicable, rather than relying on generic guidance — real-world performance depends heavily on the specific formulation matrix.

Frequently asked questions

Is BIT safer than MIT and CMIT?+
BIT has a generally lower reported sensitisation rate than CMIT specifically in published assessments, and is not restricted in EU leave-on cosmetics the way MIT and CMIT/MIT are. BIT remains classified as a skin sensitiser at the concentrated stage and requires standard biocide handling precautions.
Can BIT and MIT/CMIT be used together in the same formulation?+
Yes, this is a common commercial approach — BIT provides stable, longer-term protection while a fast-acting companion biocide provides rapid initial microbial knockdown. Confirm compatibility and dosage through formulation trials and preservative efficacy testing.
Is BIT approved under the EU Biocidal Products Regulation?+
Yes. The European Commission approved 1,2-Benzisothiazol-3(2H)-one (BIT) as an existing active substance for biocidal product-types 6 (in-can preservative) and 13 (metalworking fluid preservative) under Implementing Regulation (EU) 2025/929, published May 2025.
Which isothiazolinone is used at the highest concentration in formulations?+
BIT is typically used at higher use-concentrations (often 0.1%-0.5% of the 20% commercial solution, delivering hundreds of ppm active) than MIT or CMIT, which are usually dosed at single- to low-double-digit ppm due to their higher intrinsic potency.